SOLASTA Bio
About SOLASTA Bio
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series A T: - FT: Series A |
A: 14000000 MR: - FA: $14 million FAN: 14000000 |
D: 2024-09-11 FD: 2024-09-11 |
9 investors |
| 2 |
RT: Challenge Prize Investment T: - FT: Challenge Prize Investment |
A: 1000000 MR: - FA: US$1M FAN: 1000000 |
D: 2024-03-18 FD: 2024-03-18 |
2 investors |
Growth Metrics
Team & Leadership
Shireen Davies
Chief Executive Officer
Rob Wylie
Chair
Julian Dow
Chief Scientific Officer
David Armour
Chief Financial Officer
Daphne Preuss
Chief Business Officer
Paula Pinto
Chief Strategy Officer
Recent News
SOLASTA Bio Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- solastabio.com
- Industries
- Agritech / Biotechnology
- Company Size
- ~150 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro